MO

MO's premium cigarette strategy remains central to profitability as Marlboro holds its premium position amid rising demand for discount brands.

Altria Group remains a compelling income alternative, yielding 6.4% after its 57th consecutive annual dividend increase and robust Q2 2026 results. MO's pricing power, high margins (64.8% smokeable segment), and investment-grade balance sheet underpin reliable cash flow despite secular volume declines. MO's valuation is attractive at 12.13x forward earnings and 13x FCF, with dividend growth outpacing comparable high-yield bonds after tax.

The Dividend Harvesting Portfolio has achieved a 45.8% ROI, generating $3,289.51 in forward annual dividend income from $28,800 invested. Portfolio yield stands at 7.83% (11.42% yield on cost), with a focus on compounding and reinvestment to drive long-term income growth. Recent additions include Pfizer for value and yield (>6%,

Some investors have quietly built decades of rising income by owning stocks most people have never heard of, and five Dividend Champions with yields stretching past 7% are now drawing serious attention from Wall Street analysts.

Altria just handed shareholders a bigger check for the 60th time in 56 years, but negative operating cash flow last quarter and a vape unit bleeding billions in impairments raise a real question about whether the streak has a price.

MO's on! PLUS is gaining retail share and nationwide reach, with new strengths and flavors set to broaden its nicotine pouch lineup in 2026.

The Consumer Staples Select Sector SPDR Fund (NYSEARCA:XLP) is the default parking spot for investors who want defensive exposure, a decent dividend, and the comfort of household-name brands. It has done its job in 2026, gaining 11.

In this article series, I summarize dividend announcements of the past week. This week, 9 stocks announced dividend increases, including 3 stocks I own. INTU stands out for its robust safety metrics, 15% dividend hike, low payout ratios, and a forward-looking 16.16% dividend growth rate, though fair value estimates diverge. LRCX delivered the largest increase (26.92%) and boasts the highest Quality Score, but its yield is minimal at 0.44% and valuation appears stretched.

The U.S. Food and Drug Administration on Friday authorized the marketing of three new 'JUUL2' e-cigarette products, ​the latest in a series of approvals for ‌nicotine products the agency says may offer a lower-risk alternative to traditional cigarettes.

RICHMOND, Va.--(BUSINESS WIRE)---- $MO #Altria--Altria Announces Election of Steve Presley to Altria's Board of Directors.